SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Michael Young who wrote (5185)12/20/2001 1:41:32 PM
From: scaram(o)uche  Respond to of 52153
 
In 1997, the market wasn't created, much less penetrated. Moreover, Niaspan was going against the statins as the market was created.

Thanks for your comments, please keep them coming. I am naive here.



To: Michael Young who wrote (5185)12/20/2001 1:47:14 PM
From: scaram(o)uche  Read Replies (1) | Respond to of 52153
 
>> I don't think there is any hurry now. <<

The company was just handed cash to market what could be first in class. Market cap plus debt is now less than 650M. 5% penetration of this market is 500M/year. There is a hurry, IMO.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News